Connection
Anthony Elias to Bevacizumab
This is a "connection" page, showing publications Anthony Elias has written about Bevacizumab.
|
|
Connection Strength |
|
 |
|
 |
|
0.016 |
|
|
|
-
Ramaswamy B, Elias AD, Kelbick NT, Dodley A, Morrow M, Hauger M, Allen J, Rhoades C, Kendra K, Chen HX, Eckhardt SG, Shapiro CL. Phase II trial of bevacizumab in combination with weekly docetaxel in metastatic breast cancer patients. Clin Cancer Res. 2006 May 15; 12(10):3124-9.
Score: 0.016